AwesomeCapital
Search This Blog
Thursday, January 2, 2020
Intercept Pharma cut to Neutral from Buy by Citi
Target to $140 from $85
https://www.benzinga.com/stock/ICPT/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.